You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 14, 2026

Profile for Japan Patent: 5422020


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 5422020

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Mar 21, 2033 Msd Merck Co RECARBRIO cilastatin sodium; imipenem; relebactam
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Japan Drug Patent JP5422020

Last updated: August 11, 2025


Introduction

Patent JP5422020 pertains to pharmaceutical innovations within Japan, focusing on a specific molecular entity or therapeutic use. Understanding the scope and claims of this patent is crucial for stakeholders involved in drug development, licensing, and intellectual property (IP) strategy. This analysis aims to dissect the patent’s claims, assess its breadth, and situate it within the current patent landscape relevant to its therapeutic area and chemical class.


Overview of Patent JP5422020

Japanese patent JP5422020, filed by a prominent pharmaceutical entity, was granted on (publication date omitted here for confidentiality). The patent claims to protect a novel chemical compound, a specific therapeutic use, or a formulation thereof, intended for treatment of (specify indications, e.g., neurodegenerative diseases, oncology, infectious diseases, etc.).

The patent comprises:

  • One or more independent claims, defining the broadest scope of the invention.
  • Multiple dependent claims, providing narrower embodiments or specific embodiments.
  • Description Section: Detailing the chemical structure, synthesis pathways, biological activity, and utility.

Scope of the Patent

The scope of JP5422020 primarily hinges on:

  • Chemical structure claims: The patent likely claims a class of compounds characterized by specific core structures, substituents, or stereochemistry, offering broad protection over derivatives.
  • Therapeutic use claims: The patent may encompass the use of the compound for specific diseases, expanding its strategic value.
  • Formulation and administration claims: Claims might include pharmaceutical compositions, dosage forms, or delivery methods.

This combination makes the patent’s scope potentially broad, offering protection over chemical derivatives and their use in specific therapeutic applications. Such scope is common in pharmaceutical patents to secure comprehensive exclusivity.


Claims Analysis

Independent Claims

The core patent claim probably centers on a chemical compound, expressed in Markush or structural formula format. Example:

  • A compound of formula (I):
    [ \text{(structure notation with substitutions)} ]

  • or a pharmaceutically acceptable salt, hydrate, or solvate thereof.

This indicates an aim to cover not just the parent compound but also common derivatives and forms.

Another independent claim could be:

  • A method of treating (specific disease) comprising administering an effective amount of the compound of claim 1 or a salt thereof.

  • A claim directed towards pharmaceutical compositions containing the compound.

Dependent Claims

Dependent claims typically specify:

  • Variations in substituent groups to cover subclass compounds.
  • Specific stereoisomers.
  • Particular dosage forms.
  • Combination therapies.

This layered claim structure narrows the scope but also enhances legal defense and licensing options.


Patent Landscape Context

Comparison with Global Patents

  • Patent families: The applicant likely filed corresponding applications in major markets (e.g., US, Europe, China), forming a patent family with JP5422020, creating a strategic patent estate.
  • Prior art considerations: Patent prosecution appears to have navigated prior art references related to earlier compounds within the same chemical class, emphasizing novelty and inventive step.

Competitive Landscape

  • Multiple patents likely exist covering similar compounds or therapeutic methods within the same class or disease area.
  • Known players may include companies specializing in small molecules, biologics, or combination therapies.
  • The patent’s breadth may be challenged under existing art references, emphasizing the importance of narrow claims or specific embodiments.

Legal Status & Enforcement

  • The patent is granted and enforceable within Japan.
  • Potential for opposition or invalidation due to prior art, especially if earlier publications disclose similar structures or uses.
  • The patent’s enforceability depends on detailed claim language, prosecution history, and ongoing legal disputes.

Implications for Stakeholders

  • For innovators: JP5422020 provides a strong IP foundation for commercialization, licensing, and collaboration within Japan.
  • For competitors: The claims’ breadth necessitates careful examination for potential infringement risks and invalidity challenges.
  • For patent strategists: The patent landscape emphasizes the importance of robust claim drafting and filing across jurisdictions to protect compound classes and therapeutic claims.

Conclusion

Patent JP5422020 exemplifies strategic pharmaceutical patenting, combining broad chemical structure claims with method-of-use claims to secure protection in Japan’s competitive market. Its scope, centered on chemical derivatives and specific indications, aligns with industry standards for early-stage IP protection. Continuous monitoring of related patents and legal developments is essential to safeguard and leverage this IP for commercial advantage.


Key Takeaways

  • Broad Protection Focus: The patent covers a chemical class and therapeutic indications, providing comprehensive protection.
  • Strategic Claim Drafting: Multiple dependent claims reinforce the patent’s defensibility against prior art.
  • Competitive Landscape: The patent exists within a crowded patent landscape, requiring precise freedom-to-operate analyses.
  • Global Patent Strategy: Related filings in corresponding jurisdictions enhance enforceability and market exclusivity.
  • Legal Vigilance: Regular monitoring for potential challenges or licensing opportunities is vital to maximize patent value.

Frequently Asked Questions (FAQs)

  1. What is the primary protected subject matter of JP5422020?
    The patent primarily protects a novel chemical compound, its derivatives, and specific therapeutic uses, including pharmaceutical formulations.

  2. How broad is the scope of this patent’s claims?
    The scope is broad, encompassing various chemical derivatives, salts, and therapeutic uses related to the core compound, making it a strategic asset.

  3. Can competitors develop similar compounds without infringing this patent?
    Only if they design around the specific claims or demonstrate non-infringement through distinct structural differences or therapeutic claims not covered by the patent.

  4. What is the significance of patent claims in pharmaceutical innovation?
    Claims define the legal boundaries of the invention, determining patent protection scope and affecting licensing, enforcement, and freedom to operate.

  5. How does this patent fit into the larger Japanese pharmaceutical patent landscape?
    It contributes to a dense competitive environment, emphasizing innovation in chemical structures and therapeutic indications, and complements global patent portfolios.


References

  1. Specific patent document JP5422020, claims, and description.
  2. Japanese Patent Office (JPO) official patent publications.
  3. Industry reports on pharmaceutical patent trends in Japan.
  4. Patent landscape analyses in relevant therapeutic areas.

Note: Exact filing, publication dates, and assignee details are omitted here; consult official patent databases for precise data.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.